BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33638315)

  • 1. Opioid use by cancer status and time since diagnosis among older adults enrolled in the Prostate, Lung, Colorectal, and Ovarian screening trial in the United States.
    Durham DD; Strassels SA; Pinsky PF
    Cancer Med; 2021 Mar; 10(6):2175-2187. PubMed ID: 33638315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional and temporal variation in receipt of long-term opioid therapy among older breast, colorectal, lung, and prostate cancer survivors in the United States.
    Gibson DC; Raji MA; Baillargeon JG; Kuo YF
    Cancer Med; 2021 Mar; 10(5):1550-1561. PubMed ID: 33423372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Opioid Use Among Older Survivors of Colorectal, Lung, and Breast Cancers.
    Salz T; Lavery JA; Lipitz-Snyderman AN; Boudreau DM; Moryl N; Gillespie EF; Korenstein D
    J Clin Oncol; 2019 Apr; 37(12):1001-1011. PubMed ID: 30817249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid Use Disorder and Overdose in Older Adults With Breast, Colorectal, or Prostate Cancer.
    Roberts AW; Eiffert S; Wulff-Burchfield EM; Dusetzina SB; Check DK
    J Natl Cancer Inst; 2021 Apr; 113(4):425-433. PubMed ID: 32805032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an oncology-specific opioid risk calculator in cancer survivors.
    Riviere P; Vitzthum LK; Nalawade V; Deka R; Furnish T; Mell LK; Rose BS; Wallace M; Murphy JD
    Cancer; 2021 May; 127(9):1529-1535. PubMed ID: 33378556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Opioid Therapy in Older Cancer Survivors: A Retrospective Cohort Study.
    Shah R; Chou LN; Kuo YF; Raji MA
    J Am Geriatr Soc; 2019 May; 67(5):945-952. PubMed ID: 31026356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Taylor KL; Luta G; Miller AB; Church TR; Kelly SP; Muenz LR; Davis KM; Dawson DL; Edmond S; Reding D; Mabie JE; Riley TL
    J Clin Oncol; 2012 Aug; 30(22):2768-75. PubMed ID: 22734029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
    Gohagan JK; Prorok PC; Hayes RB; Kramer BS;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain.
    Lakkad M; Martin B; Li C; Harrington S; Dayer L; Painter JT
    J Cancer Surviv; 2024 Jun; 18(3):917-927. PubMed ID: 36753003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Long-Term Prescription Opioid Use Among Older Adults in the United States: A Study of Medicare Administrative Claims Data.
    Ramachandran S; Salkar M; Bentley JP; Eriator I; Yang Y
    Pain Physician; 2021 Jan; 24(1):31-40. PubMed ID: 33400426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of long-term use of prescription opioids in the community-dwelling population of adults without a cancer diagnosis: a retrospective cohort study.
    Béliveau A; Castilloux AM; Tannenbaum C; Vincent P; de Moura CS; Bernatsky S; Moride Y
    CMAJ Open; 2021; 9(1):E96-E106. PubMed ID: 33563639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of an Opioid-Related Emergency Department Visit or Hospitalization Among Older Breast, Colorectal, Lung, and Prostate Cancer Survivors.
    Gibson DC; Raji MA; Holmes HM; Baillargeon JG; Kuo YF
    Mayo Clin Proc; 2022 Mar; 97(3):560-570. PubMed ID: 35135691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer.
    Winn AN; Check DK; Farkas A; Fergestrom NM; Neuner JM; Roberts AW
    JAMA Netw Open; 2020 Sep; 3(9):e2016858. PubMed ID: 32930779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid and Other Medication Use and General Health Status in a Cohort of Older Adults.
    Pinsky PF; Durham D; Strassels S
    Gerontology; 2021; 67(5):554-562. PubMed ID: 33691305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.
    Lamerato LE; Marcus PM; Jacobsen G; Johnson CC
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):827-33. PubMed ID: 18398023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-related Events.
    Yaldo A; Wen L; Ogbonnaya A; Valderrama A; Kish J; Eaddy M; Kreilick C; Tangirala K; Shields K
    Clin Ther; 2016 Aug; 38(8):1880-9. PubMed ID: 27478111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial.
    Prorok PC; Wright P; Riley TR; Kramer BS; Berg CD; Gohagan JK
    Rev Recent Clin Trials; 2018; 13(4):257-273. PubMed ID: 29629665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.
    O'Grady TJ; Kitahara CM; DiRienzo AG; Boscoe FP; Gates MA
    PLoS One; 2014; 9(9):e106880. PubMed ID: 25192282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Stallings FL; Ford ME; Simpson NK; Fouad M; Jernigan JC; Trauth JM; Miller DS;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):379S-389S. PubMed ID: 11189689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.